Ratings by Raymond James (Danielle Brill)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/22/2021 Global Blood Therapeutics GBT Maintain Market Perform
(N/A)
 
 
  Details
6/1/2021 Immunovant IMVT Downgrade Market Perform
(Outperform)
15.16
(11.00)
-27.44% Details
5/6/2021 uniQure BV QURE Maintain Strong Buy
(N/A)
 
 
  Details
4/5/2021 Acadia Pharmaceuticals ACAD Downgrade Market Perform
(Outperform)
25.59
(25.01)
-2.27% Details
3/9/2021 Acadia Pharmaceuticals ACAD Downgrade Outperform
(Strong Buy)
45.78
(25.59)
-44.1% Details
2/2/2021 Immunovant IMVT Maintain Outperform
(N/A)
 
 
  Details
2/2/2021 Neurocrine Bio. NBIX New Coverage Outperform
(N/A)
109.75
(100.58)
-8.36% Details
2/1/2021 argenx SE ARGX Maintain Outperform
(N/A)
 
 
  Details
1/19/2021 Acceleron Pharma XLRN Maintain Strong Buy
(N/A)
 
 
  Details
1/8/2021 Sarepta Therapeutics SRPT Downgrade Market Perform
(Outperform)
166.45
(79.68)
-52.13% Details
12/31/2020 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
12/16/2020 PTC Therapeutics PTCT Maintain Outperform
(N/A)
 
 
  Details
11/16/2020 Acadia Pharmaceuticals ACAD Upgrade Strong Buy
(Outperform)
50.61
(45.78)
-9.54% Details
11/6/2020 Global Blood Therapeutics GBT Downgrade Market Perform
(Outperform)
61.88
(36.44)
-41.11% Details
10/26/2020 FibroGen FGEN New Coverage Underperform
(N/A)
42.60
(29.09)
-31.71% Details
8/25/2020 Immunovant IMVT Maintain Outperform
(N/A)
 
 
  Details
8/25/2020 Zogenix, Inc. ZGNX New Coverage Market Perform
(N/A)
22.94
(17.99)
-21.58% Details
8/25/2020 Sarepta Therapeutics SRPT New Coverage Outperform
(N/A)
141.94
(79.68)
-43.86% Details
8/25/2020 uniQure BV QURE New Coverage Strong Buy
(N/A)
38.52
(30.11)
-21.83% Details
8/25/2020 PTC Therapeutics PTCT New Coverage Outperform
(N/A)
48.58
(44.14)
-9.14% Details
8/25/2020 Momenta Pharmaceuticals MNTA New Coverage Market Perform
(N/A)
52.32
(52.48)
0.31% Details
8/25/2020 GW Pharma GWPH New Coverage Market Perform
(N/A)
109.31
(218.96)
100.31% Details
8/25/2020 Global Blood Therapeutics GBT New Coverage Outperform
(N/A)
65.76
(36.44)
-44.59% Details
8/25/2020 Immunovant IMVT New Coverage Outperform
(N/A)
32.59
(15.16)
-53.48% Details
8/25/2020 argenx SE ARGX New Coverage Outperform
(N/A)
236.18
(314.47)
33.15% Details
8/25/2020 Acadia Pharmaceuticals ACAD New Coverage Outperform
(N/A)
38.32
(25.01)
-34.73% Details